Form 4 holding
Bd. Co-Chair, President & CEO, Director
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 300,000
- Estimated value
- $207,774,000
- Report date
- 31 Dec 2025
- Price
- $692.58
- Ownership
- By 2025 GRAT